Calif. Pharmacies Sue Pfizer, Ranbaxy Over Lipitor Deal

Law360, New York (November 8, 2011, 10:01 PM EST) -- Eleven California pharmacies sued Pfizer Inc., generics maker Ranbaxy Pharmaceuticals Inc. and others on Monday, saying an anti-competitive agreement between the drug companies forced them to pay higher prices for the cholesterol treatment Lipitor for longer than necessary.

The agreement between Pfizer and Ranbaxy — which was the first company to challenge Pfizer's patents on Lipitor when it filed its abbreviated new drug application nine years ago — has delayed the entry of generic versions of Lipitor into the U.S. market for up to 20 months...
To view the full article, register now.